Mirador Therapeutics
PrivateLast Round
Series B
Jan 12, 2026
Total Funding Raised
$1.15B
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mirador Therapeutics is a biotechnology company that develops precision medicines for immune-mediated inflammatory and fibrotic diseases using its proprietary Mirador360™ discovery and development engine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirador Therapeutics Comparables
Compare Mirador Therapeutics with similar companies based on industry and business-model similarity.
Mirador Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Series B | Sep 30, 2025 | ||||
| Series A | Mar 21, 2024 |
Mirador Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Farallon Capital Management | Series B, Series A |
| TCG Crossover | Series B, Series A |
| Boxer Capital | Series B, Series A |
| Fairmount Funds Management | Series B, Series A |
| ARCH Venture Partners | Series B, Series A |
| Fidelity Management & Research Company | Series B, Series A |
| Blue Owl Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 113% MoM, reaching 10K.
- Jan 12, 2026
$250M round with participation from Venrock and Adage Capital.
Mirador Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mirador Therapeutics's valuation, stock price, and market status.
Is Mirador Therapeutics a public or private company?
Mirador Therapeutics is a private company.
What is the current stock price of Mirador Therapeutics?
Mirador Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mirador Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mirador Therapeutics worth (valuation)?
Valuation information for Mirador Therapeutics is not publicly available.
Can I buy Mirador Therapeutics stock?
Mirador Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mirador Therapeutics's last funding round?
Mirador Therapeutics's most recent funding round was Series B on January 12, 2026.
Who are the main investors in Mirador Therapeutics?
Key investors in Mirador Therapeutics include ARCH Venture Partners, Fidelity Management & Research Company, ARCH Venture Partners, T. Rowe Price, Adage Capital Partners, L.P..
Will Mirador Therapeutics IPO soon?
No public IPO plans have been announced for Mirador Therapeutics.
How can I track Mirador Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mirador Therapeutics's shares on secondary markets.